Acetic Acid → HCID 58000512, compound
Reaction equation
[NH2:1][C:2]1[S:3][CH:4]=[C:5]([CH2:7][N:8]([CH3:39])[C:9]2[N:14]=[C:13]([Cl:15])[N:12]=[C:11]([NH:16][NH:17][C:18](=[O:37])[C@H:19]([CH2:31][CH:32]3[CH2:36][CH2:35][CH2:34][CH2:33]3)[CH2:20][N:21]([O:24]C3CCCCO3)[CH:22]=[O:23])[C:10]=2[F:38])[N:6]=1.CC(O)=O>O>[NH2:1][C:2]1[S:3][CH:4]=[C:5]([CH2:7][N:8]([CH3:39])[C:9]2[N:14]=[C:13]([Cl:15])[N:12]=[C:11]([NH:16][NH:17][C:18](=[O:37])[C@H:19]([CH2:31][CH:32]3[CH2:33][CH2:34][CH2:35][CH2:36]3)[CH2:20][N:21]([OH:24])[CH:22]=[O:23])[C:10]=2[F:38])[N:6]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
[(2R)-3-(2-{6-[[(2-Amino-1,3-thiazol-4-yl)methyl](methyl)amino]-2-chloro-5-fluoro-4-pyrimidinyl}hydrazino)-2-(cyclopentylmethyl)-3-oxopropyl](tetrahydro-2H-pyran-2-yloxy)formamide (110 mg, 0.19 mmol) in 4:1 AcOH:water (5 mL) was stirred at room temperature for 2 days. The solvents were removed in vacuo, and the resulting crude product was purified by RP-HPLC to provide N-[(2R)-3-[2-(6-{[(2-amino-1,3-thiazol-4-yl)methyl](methyl)amino}-2-chloro-5-fluoro-4-pyrimidinyl)hydrazino]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide (20 mg, 21%). LCMS: (M+H)+: 501.1.
Workup
- customThe solvents were removed in vacuo
- customthe resulting crude product was purified by RP-HPLC
Sources & evidence
- ORD record
- ord-091a7438e8664b329553d66e69de1c14
- Source dataset
- uspto-grants-2011_02
- Patent number
- US07893056B2
Reaction notes
Loading…